Smoking exacerbates amyloid pathology in a mouse model of Alzheimer's disease

Nature Communications

Volumn 4, Issue , 2013, Pages

  Moreno Gonzalez, Ines ^a   Estrada, Lisbell D ^b,c   Sanchez Mejias, Elisabeth ^d   Soto, Claudio ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSIDAD BERNARDO O'HIGGINS   (Chile)

^d UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; CIGARETTE SMOKE; TAU PROTEIN;

ALKALOID; DISEASE INCIDENCE; ENVIRONMENTAL RISK; EPIDEMIOLOGY; NERVOUS SYSTEM DISORDER; NEUROLOGY; RODENT; SMOKING;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HIPPOCAMPUS; IN VIVO STUDY; INHALATION; MALE; MOUSE; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; PROTEIN PHOSPHORYLATION; SMOKING;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; ANIMALS; COTININE; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HUMANS; MICE; MICE, TRANSGENIC; MICROGLIA; NERVE DEGENERATION; PHOSPHORYLATION; PRESENILIN-1; SMOKING; TAU PROTEINS;

EID: 84874629047     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2494     Document Type: Article

References (40)

1. Querfurth, H. W. & LaFerla, F. M. Alzheimer's disease. N. Engl. J. Med 362, 329-344 (2010)
2. Holtzman, D. M., Goate, A., Kelly, J. & Sperling, R. Mapping the road forward in Alzheimer's disease. Sci. Transl. Med. 3, 114ps48 (2011)
3. Barnes, D. E. & Yaffe, K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 10, 819-828 (2011)
4. Flicker, L. Modifiable lifestyle risk factors for Alzheimer's disease. J. Alzheimers. Dis. 20, 803-811 (2010)
5. Lindsay, J. et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am. J. Epidemiol. 156, 445-453 (2002) (Pubitemid 34976983)
6. Brenner, D. E. et al. Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology 43, 293-300 (1993) (Pubitemid 23060258)
7. Lee, P. N. Smoking and Alzheimer's disease: a review of the epidemiological evidence. Neuroepidemiology 13, 131-144 (1994) (Pubitemid 24197313)
8. Jones, G. M., Sahakian, B. J., Levy, R., Warburton, D. M. & Gray, J. A. Effects of acute subcutaneous nicotine on attention, information processing and shortterm memory in Alzheimer's disease. Psychopharmacology (Berl) 108, 485-494 (1992)
9. Newhouse, P. A., Potter, A. & Levin, E. D. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Drugs Aging 11, 206-228 (1997) (Pubitemid 27421319)
10. Utsuki, T. et al. Nicotine lowers the secretion of the Alzheimer's amyloid betaprotein precursor that contains amyloid beta-peptide in rat. J. Alzheimers. Dis. 4, 405-415 (2002) (Pubitemid 35397806)
11. Lahiri, D. K. et al. Nicotine reduces the secretion of Alzheimer's beta-amyloid precursor protein containing beta-amyloid peptide in the rat without altering synaptic proteins. Ann. N. Y. Acad. Sci. 965, 364-372 (2002) (Pubitemid 34721984)
12. Salomon, A. R., Marcinowski, K. J., Friedland, R. P. & Zagorski, M. G. Nicotine inhibits amyloid formation by the beta-peptide. Biochemistry 35, 13568-13578 (1996) (Pubitemid 26359169)
13. Dickerson, T. J. & Janda, K. D. A previously undescribed chemical link between smoking and metabolic disease. Proc. Natl Acad. Sci. USA 99, 15084-15088 (2002) (Pubitemid 35334613)
14. Nordberg, A. et al. Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw). J. Neurochem. 81, 655-658 (2002) (Pubitemid 34809344)
15. Srivareerat, M., Tran, T. T., Salim, S., Aleisa, A. M. & Alkadhi, K. A. Chronic nicotine restores normal Abeta levels and prevents short-term memory and E-LTP impairment in Abeta rat model of Alzheimer's disease. Neurobiol. Aging 32, 834-844 (2011)
16. Echeverria, V. et al. Cotinine reduces amyloid-beta aggregation and improves memory in Alzheimer's disease mice. J. Alzheimers. Dis. 24, 817-835 (2011)
17. Hellstrom-Lindahl, E., Mousavi, M., Ravid, R. & Nordberg, A. Reduced levels of Abeta 40 and Abeta 42 in brains of smoking controls and Alzheimer's patients. Neurobiol. Dis. 15, 351-360 (2004) (Pubitemid 38296766)
18. Ott, A. et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 351, 1840-1843 (1998) (Pubitemid 28279707)
19. Reitz, C., den, H. T., van, D. C., Hofman, A. & Breteler, M. M. Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study. Neurology 69, 998-1005 (2007) (Pubitemid 47366053)
20. Anstey, K. J., von, S. C., Salim, A. & O'Kearney, R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am. J. Epidemiol. 166, 367-378 (2007) (Pubitemid 47216800)
21. Cataldo, J. K., Prochaska, J. J. & Glantz, S. A. Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation. J. Alzheimers. Dis. 19, 465-480 (2010)
22. Ulrich, J., Johannson-Locher, G., Seiler, W. O. & Stahelin, H. B. Does smoking protect from Alzheimer's disease? Alzheimer-type changes in 301 unselected brains from patients with known smoking history. Acta Neuropathol. 94, 450-454 (1997) (Pubitemid 27483209)
23. Tyas, S. L. et al. Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study. Neurobiol. Aging 24, 589-596 (2003) (Pubitemid 36513707)
24. Riggs, J. E. Smoking and Alzheimer's disease: protective effect or differential survival bias? Lancet 342, 793-794 (1993) (Pubitemid 23279809)
25. Sabbagh, M. N. et al. Smoking affects the phenotype of Alzheimer disease. Neurology 64, 1301-1303 (2005)
26. Oddo, S. et al. Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 102, 3046-3051 (2005) (Pubitemid 40299913)
27. Juan, D., Zhou, D. H., Li, J., Wang, J. Y., Gao, C. & Chen, M. A 2-year follow-up study of cigarette smoking and risk of dementia. Eur. J. Neurol. 11, 277-282 (2004) (Pubitemid 38491102)
28. Richards, M., Jarvis, M. J., Thompson, N. & Wadsworth, M. E. Cigarette smoking and cognitive decline in midlife: evidence from a prospective birth cohort study. Am. J. Public Health 93, 994-998 (2003) (Pubitemid 38480234)
29. Almeida, O. P., Garrido, G. J., Lautenschlager, N. T., Hulse, G. K., Jamrozik, K. & Flicker, L. Smoking is associated with reduced cortical regional gray matter density in brain regions associated with incipient Alzheimer disease. Am. J. Geriatr. Psychiatry 16, 92-98 (2008)
30. Benowitz, N. L. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol. Rev. 18, 188-204 (1996) (Pubitemid 27082089)
31. Seccareccia, F. et al. Serum cotinine as a marker of environmental tobacco smoke exposure in epidemiological studies: the experience of the MATISS project. Eur. J. Epidemiol. 18, 487-492 (2003) (Pubitemid 36899552)
32. Breu-Villaca, Y. et al. Exposure to tobacco smoke containing either high or low levels of nicotine during adolescence: differential effects on choline uptake in the cerebral cortex and hippocampus. Nicotine. Tob. Res. 12, 776-780 (2010)
33. Jankowsky, J. L., Slunt, H. H., Ratovitski, T., Jenkins, N. A., Copeland, N. G. & Borchelt, D. R. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol. Eng. 17, 157-165 (2001) (Pubitemid 32409891)
34. Garcia-Alloza, M. et al. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol. Dis. 24, 516-524 (2006) (Pubitemid 44716680)
35. Tuppo, E. E. & Arias, H. R. The role of inflammation in Alzheimer's disease. Int. J. Biochem. Cell Biol. 37, 289-305 (2005) (Pubitemid 39330191)
36. Leone, C. et al. Characterization of human monocyte-derived microglia-like cells. Glia 54, 183-192 (2006) (Pubitemid 44230855)
37. Hernandez, F. & Avila, J. The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease. FEBS Lett. 582, 3848-3854 (2008)
38. Takashima, A. GSK-3 is essential in the pathogenesis of Alzheimer's disease. J. Alzheimers. Dis. 9, 309-317 (2006) (Pubitemid 44253325)
39. Goedert, M., Jakes, R. & Vanmechelen, E. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci. Lett. 189, 167-169 (1995)
40. Games, D., Buttini, M., Kobayashi, D., Schenk, D. & Seubert, P. Mice as models: transgenic approaches and Alzheimer's disease. J. Alzheimers. Dis. 9, 133-149 (2006). (Pubitemid 44255487)